Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesCD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expressionFacilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 BlockadeCo-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamilyThe current status of therapeutic HPV vaccineWhy do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?Autoaggression and tumor rejection: it takes more than self-specific T-cell activation.Progress in cancer gene therapy.The diversity of T-cell co-stimulation in the induction of antitumor immunity.Cell-based vaccines for the stimulation of immunity to metastatic cancers.T-cell recognition of melanoma-associated antigens.The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease.Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivoConstruction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).Gene therapy: development of immunostimulatory treatments for cancer.Interleukin-12 gene therapy vaccines: directing the immune system against minimal residual leukemia.Malignancy: Gene Therapy Vaccines in Acute Myeloid Leukemia : A Need for Clinical Evaluation.AAV2-mediated in vivo immune gene therapy of solid tumours.Assumptions of the tumor 'escape' hypothesis.Cancer vaccines: progress reveals new complexities.Therapeutic vaccination with tumor cells that engage CD137.Mouse model for pre-clinical study of human cancer immunotherapy.Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.Antigen-presenting cell engineering. The molecular toolboxB7 molecule mRNA expression in colorectal carcinomaChallenges and future perspectives of T cell immunotherapy in cancerThe tumor protection effect of high-frequency administration of whole tumor cell vaccine and enhanced efficacy by the protein component from Agrocybe aegerita.Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16.Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccinesMajor histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing miceA reassessment of the role of B7-1 expression in tumor rejection.Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytesB7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism.Expression of B7 costimulation molecules by colorectal cancer cells reducestumorigenicity and induces anti-tumor immunity.Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.
P2860
Q24551158-5889A6A9-C611-4219-8358-43BD73BA2C6BQ24808883-6965A5E4-4E5D-453C-A667-2308CAF56CBCQ28119095-D466C68A-F3E1-409B-9591-E80D1F1AC5E6Q28271806-C2523C9D-3118-46A9-ABC6-56ABB646B8E8Q28302676-44836CA6-2D04-4FCE-A862-52B7F4FF467CQ33536297-7F14CC7C-4449-4779-84AB-33043806832AQ33713362-2C0936C1-80DB-481F-844A-781F6D74FDD2Q33752288-9EBD4D33-3E53-440E-97D1-21D1D8C8E284Q33776121-D61BDA56-3C94-44FE-8DE5-BA56718B9F35Q33776134-9E02AB5D-DBA6-4FD6-B675-9B44A2BB2FFEQ33827458-7711325C-E5D8-4B2B-B180-721DB09C5046Q33836317-E1E9F828-A2DB-446E-940C-F928BE72F33BQ33870240-29A86B80-4779-4C08-A47D-D9788F606E0EQ34027192-3C9DDFC3-7CF4-4551-B8A8-45CA6088722AQ34187915-84AF7F7C-E65F-40E7-BAFA-CB0A84B20ED2Q34265227-EFBB24E2-B43E-4306-B308-C9B7DFA28460Q34278291-DD831E85-B45D-4CE0-AFF9-F13613095343Q34468330-4FAAE9E4-56F9-4A7B-B071-7537AF6A0D83Q34583258-0B6052E6-D174-4B35-86D1-E58016A7C7E8Q34774541-E63DD59D-3622-4AFE-9B0A-0B6C59E43E58Q35071688-A14393C1-5AC5-41F3-AC98-1A5D3CD696D3Q35181705-1DDDA5C2-6B49-45CC-A5E9-4CBA1F26A733Q35580479-932FDBC1-0290-4AF3-A4A5-7BB92EC7A32CQ35664087-C2F8E43D-D19B-4D3A-B51E-E8CB42F2A8D7Q35773889-5648AFC8-6DF7-416D-AE74-2393FDFAB3CAQ35784085-99EB74B2-1E37-4CCF-B75B-C1A6B528270FQ35843507-8F9F8181-1337-4DBE-BCF4-AE9A8C531FC1Q35870629-4E3A4A50-E917-49FE-8FFB-6F4CDE38ABEFQ35883954-A7BA3435-7827-4EC0-A2B7-30B6355D6DB6Q35963911-D8183D21-E99F-4DAC-BD51-0E227A306030Q36308644-ABB0550C-B6A6-47B7-ADDB-0F6D2B7D5589Q36364365-001AE4B3-7970-4DCF-8087-A82601AB01BBQ36365375-324D3C21-CDA3-4F7F-B277-182B658F021CQ36365923-17BF7E4E-A9C6-4EC7-A5FA-3B87D4311223Q36365932-3718FA27-CE85-4FC3-82E8-E8A7426CFCACQ36366207-4F615742-7AAE-4ACD-9AF4-95410487F261Q36367022-C28E2047-3AD2-4151-9316-46FA0E0EEB4AQ36368136-005EF742-CC42-4129-876C-6097529EE330Q36396919-BC740C02-0A28-4C62-97C8-47F8EE18A45BQ36470722-CCE195D8-53B2-414E-80BE-C42F5AB9796A
P2860
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@ast
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@en
type
label
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@ast
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@en
prefLabel
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@ast
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@en
P2093
P2860
P356
P1476
Tumor immunogenicity determine ...... cell-mediated tumor immunity.
@en
P2093
Hellström I
Hellström KE
Johnston J
P2860
P304
P356
10.1084/JEM.179.2.523
P407
P577
1994-02-01T00:00:00Z